Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Reflux Cases

The consequences of prophylactic PPI therapy

    • Gastroenterology and Hepatology
    • Partner Content
    • RX
  • 2 minute read

A 28-year-old patient presents with persistent reflux symptoms that first appear after discontinuation of PPI therapy.

Background: A 28-year-old patient experienced gastric burning and occasional thoracic pain for the first time after discontinuation of prophylactic therapy with proton pump inhibitors (PPI). Six months ago, the patient suffered a skiing accident with a compound fracture of the left elbow. Surgery was required to stabilize the fracture. To reduce pain and swelling, the patient was prescribed 400 mg of ibuprofen three times daily. In addition, he received prophylactic PPI therapy with 40 mg pantoprazole daily as “gastric protection.” There were no complications and the patient had no abdominal discomfort. A few weeks after the injury, the patient stopped all medications. Shortly thereafter, he experienced intermittent stomach burning and thoracic pain. The reflux symptoms improved after renewed regular intake of pantoprazole. Repeated attempts to discontinue PPI medication were unsuccessful.

History and diagnosis: The patient had no history of digestive or other diseases and was not overweight. He was a nonsmoker, drank little alcohol, and took no other medications. Laboratory tests were unremarkable. Endoscopy was performed to clarify persistent symptoms. There was no evidence of reflux esophagitis, hiatal hernia, or peptic ulceration. Helicobacter pylori infection could also be excluded.

Therapy: Instead of discontinuing the drug immediately, the patient was advised to slowly taper the dose of the acid-inhibiting drug. First, the dose was reduced from 20 mg to 10 mg pantoprazole daily and then to once daily every 2-3 days for one month. In addition, the patient was prescribed 5 ml of the liquid alginate antacid preparation Gaviscon® after meals and later only when symptoms occurred. Under this treatment, he was completely symptom-free within a month. Pantoprazole could be discontinued without problems after only two weeks of alginate therapy. One month later, the patient rarely needed to take alginate on an as-needed basis.

Comment by Prof. Dr. med. Mark Fox: The case impressively demonstrates the so-called acid rebound effect after discontinuation of PPI therapy. For example, clinical studies show that at least one in four healthy volunteers who have been administered acid-inhibiting drugs suffer from stomach burn or other reflux symptoms after therapy has ended. This effect is due to a greatly increased level of gastrin in the blood as a result of PPI therapy. This hormone stimulates acid secretion, which may cause the symptoms due to hyperacidity after discontinuation of the drug. This acid rebound can last for several weeks. Prescribing Gaviscon® may facilitate dose reduction and ultimately discontinuation of PPI therapy.

In addition, it should be mentioned that routine prescribing of anti-acid medications is not recommended in patients who require short-term treatment with ibuprofen or other non-steroidal anti-inflammatory and analgesic medications. This practice is one of the reasons for the widespread overprescribing of PPI medications in the professional community.

More articles on the topic

  • Reflux cases: mild reflux symptoms after pregnancy
  • Reflux cases: worsening of decades-old reflux symptoms.
  • Reflux cases: grade 1 obesity as a risk factor
  • Reflux Cases: Low-dose therapeutic approach without success
  • Reflux Cases: When reflux is not reflux
  • Reflux cases: pain here, there and everywhere
  • 7 reflux phenotypes at a glance
     
Autoren
  • Prof. Dr. med. Mark Fox
Related Topics
  • gaviscon
  • PPI
  • Proton pump inhibitors
  • Reflux
  • Reflux Update
Previous Article
  • Carotid stenosis

Overview of current treatment options

  • Cardiology
  • Education
  • Neurology
  • RX
  • Studies
View Post
Next Article
  • On our own account

Tanja Schliebe is the new Editor-in-Chief

  • News
  • RX
View Post
You May Also Like
View Post
  • 2 min
  • Chronic pain

Nano-ECS modulator Adezunap improves therapy success

    • Congress Reports
    • General Internal Medicine
    • Pharmaceutical medicine
    • Pharmacology and toxicology
    • Phytotherapy
    • Rheumatology
    • RX
    • Studies
View Post
  • 8 min
  • Psoriasis and PsA

Biologics, oral peptide and trivalent nanobody – current results and trends

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Rheumatology
    • RX
    • Studies
View Post
  • 5 min
  • Cancer in Europe: facts and analysis

New Health Policy Report published

    • General Internal Medicine
    • Oncology
    • Practice Management
    • Prevention and health care
    • RX
    • Studies
View Post
  • 4 min
  • Gastrointestinal complaints

PPI regulation under the microscope

    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 6 min
  • Wound management: clinical diagnostics

Assessing the risk of infection – from the ABCDE to the TILI score

    • Congress Reports
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Geriatrics
    • Infectiology
    • Interviews
    • Physical medicine and rehabilitation
    • Prevention and health care
    • RX
View Post
  • 4 min
  • Study report

Digital patient education for atrial fibrillation shows measurable effects

    • Cardiology
    • Education
    • General Internal Medicine
    • RX
    • Studies
View Post
  • 4 min
  • New practice guideline for fibromyalgia syndrome

Good times, bad times

    • Congress Reports
    • General Internal Medicine
    • Neurology
    • Pharmacology and toxicology
    • Physical medicine and rehabilitation
    • Rheumatology
    • RX
    • Sports Medicine
    • Studies
View Post
  • 23 min
  • Important basics and studies on cancer and the psyche

Interplay between cancer and mental illness

    • CME continuing education
    • Oncology
    • Psychiatry and psychotherapy
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
Top CME content
  • 1
    How combination therapies lead to better treatment results
  • 2
    Interplay between cancer and mental illness
  • 3
    PH and lung diseases
  • 4
    Treatment of comorbidities in older people
  • 5
    Multidisciplinary teams in oncology

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.